SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is a major focus for investors ahead of its anticipated earnings, sparking polarized community discussions with many viewing the recent pullback as a significant buying opportunity. The market is keenly watching its extensive AI infrastructure investments, including strategic data center expansions and key partnerships like Rezolve AI, while also scrutinizing the tangible monetization of its AI initiatives amidst growing concerns about energy demands.

Bitmine Immersion Technologies, Inc. is a technology company focused on acquiring, holding, and actively managing ETH as its primary treasury reserve asset. It prioritizes digital ecosystem services, such as consultancy and advisory works. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

Bitmine Immersion Technologies Inc

Bitmine Immersion Technologies is trending after its $200 million equity investment in MrBeast's Beast Industries and the approval of a significant increase in authorized shares. Community sentiment is sharply divided, with many investors expressing frustration over the perceived diversion from the core Ethereum treasury strategy and concerns about potential dilution. Conversely, supporters view the MrBeast deal as a strategic 'moonshot' to diversify and engage younger demographics with future crypto-backed products, maintaining conviction in the company's long-term vision.

Springview Holdings Ltd. engages in the design and construction of residential and commercial buildings. It involves new construction, reconstruction, alterations, and other general contracting services. The company was founded in 2002 and is headquartered in Singapore.

Springview Holdings Ltd - Ordinary Shares - Class A

Springview Holdings Ltd

Springview Holdings (SPHL) is trending due to a parabolic surge, fueled by its extremely low share float and recent pivot into solar and green microgrids in Singapore. The community is actively discussing significant, 'life-changing' gains and a potential short squeeze, with many comparing its rapid ascent to other high-volatility low-float runners while acknowledging the inherent risks.

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

Lucid Group is trending as investors weigh its reported achievement of annual production and delivery targets, alongside the unveiling of a robotaxi partnership with Uber and Nvidia, against persistent concerns. Community discussion highlights deep divisions, with optimists pointing to technological innovation and operational progress, while critics focus on ongoing cash burn, stock dilution, and management performance, driving significant bearish sentiment.

Figma, Inc. is an AI-powered design platform that enables seamless collaboration across the entire product development lifecycle. Its products include FigJam, Figma Slides, Figma Design, Figma Draw, Dev Mode, Figma Sites, Figma Buzz and Figma Make. The company was founded by Dylan Joseph Field and Evan Darrow Wallace in 2012 and is headquartered in San Francisco, CA.

Figma Inc. - Ordinary Shares - Class A

Figma

Figma ($FIG) is currently experiencing significant selling pressure, driving its stock to new lows, even falling below its IPO price, with community discussions heavily centered on ongoing insider selling and upcoming lockup expirations. Sentiment remains sharply divided, as many traders express concern over AI's potential to disrupt UI design, while others view the depressed valuation as a compelling long-term buying opportunity. The market is actively debating Figma's competitive landscape against established players like Adobe and emerging AI-powered design tools.

Moolec Science SA engages in the development and production of science-based food ingredients. Its products include pet food, animal feed, and dietary supplements. The company was founded by Gastón Paladini, Henk Hoogenkamp, and Martin Salinas in 2020 and is headquartered in George Town, Cayman Islands.

Moolec Science SA

Moolec Science (MLEC) is trending following a significant reverse stock split, drastically reducing its share float and igniting community speculation about a massive short squeeze. Traders are closely watching for explosive moves, drawing comparisons to other recent low-float runners. This enthusiasm is further fueled by recent regulatory approval for its safflower technology in Argentina and expanded acreage in the US, creating high expectations for volatility.

Summit State Bank engages in providing an array of financial services to small and medium-sized businesses, their owners and employees, entrepreneurs, high net worth families, foundations, estates, and individual consumers. It specializes in business services, personal accounts, nonprofit programs, and mobile banking ranging from lending, checking, merchant, eBanking, automated teller machines, equity loans, and others. The company was founded on December 20, 1982 and is headquartered in Santa Rosa, CA.

Summit State Bank

Summit St. Bank

Summit State Bank is trending due to recent market volatility and its Q1 2025 earnings report, which coincides with the stock reaching a 52-week low. The community is focused on the bank's significant exposure to the struggling California wine industry, prompting concerns over potential loan defaults and broader financial stability within the regional banking sector. While some anticipate a technical rebound, investors are closely monitoring management's efforts to maintain credit quality and strong capital ratios amidst these challenges.

Regentis Biomaterials Ltd. engages in the development of tissue repair solutions. It focuses on orthopedic treatments through its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue such as inflamed cartilage and bone tissue. The company was founded by Dror Seliktar and Tal Yehiel on September 1, 2004 and is headquartered in Or-Akiva, Israel.

Regentis Biomaterials Ltd.

Regentis Biomaterials

Regentis Biomaterials (RGNT) is trending as a recently public company, following positive clinical trial results for its GelrinC liquid formulation and the granting of a new U.S. patent. The community is actively discussing its extremely low public float and insider lock-up, fueling speculation about a potential short squeeze and significant upward movement as many call for increased volume and further positive news.

The VGX token serves as a cross-platform and cross-chain token focused on the gaming space. The goal of the VGX Foundation is to partner with projects and companies to integrate VGX in games and platforms, offering rewards and ownership for players regardless of the chain the game is built on.

Voyager Token

VGX is actively discussed due to recent distributions from the ongoing Voyager Digital bankruptcy proceedings and a notable price surge that has sparked both confusion and sharp warnings from the community. Many former users express deep frustration and skepticism, viewing the token as a persistent reminder of significant losses and questioning the integrity of its continued trading. The prevailing sentiment is a mix of wary observation and a strong call for accountability regarding past events.

BitVentures Ltd. engages in the provision of financial services. Its services include wealth management, insurance brokerage, and asset management. The company was founded by Hongwei Han in July 19, 2019 and is headquartered in Shanghai, China.

BitVentures Ltd.

BitVentures Ltd. - ADR

BitVentures Ltd. (BVC) is a top trending stock, with community discussion centered on its recent reverse stock split that significantly reduced its public float. This low float, coupled with a crypto-related narrative and high insider ownership, has fueled speculation among investors about potential for explosive price movement, leading to trading halts and a mix of excitement and cautious observation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

All You Need to Know About X4 Pharmaceuticals (XFOR) Rating Upgrade to Buy

X4 Pharmaceuticals (XFOR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Given Consensus Rating of "Hold" by Analysts

X4 Pharmaceuticals, Inc. (NASDAQ:XFOR - Get Free Report) has been assigned a consensus rating of "Hold" from the five ratings firms that are currently covering the company, Marketbeat reports. One...

Short Interest in X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Grows By 27.1%

X4 Pharmaceuticals, Inc. (NASDAQ:XFOR - Get Free Report) was the target of a large increase in short interest in the month of December. As of December 15th, there was short interest totaling...

Should You Buy X4 Pharmaceuticals (XFOR) After Golden Cross?

When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?

X4 Pharmaceuticals, Inc. $XFOR Shares Sold by Acorn Capital Advisors LLC

Acorn Capital Advisors LLC lowered its stake in shares of X4 Pharmaceuticals, Inc. (NASDAQ:XFOR - Free Report) by 97.9% in the second quarter, according to the company in its most recent filing with...

X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Receives Consensus Recommendation of "Hold" from Brokerages

Shares of X4 Pharmaceuticals, Inc. (NASDAQ:XFOR - Get Free Report) have been given an average rating of "Hold" by the five ratings firms that are presently covering the stock, Marketbeat.com reports...

X4 Pharmaceuticals (NASDAQ:XFOR) Stock Rating Lowered by Zacks Research

Zacks Research lowered shares of X4 Pharmaceuticals from a "strong-buy" rating to a "hold" rating in a report on Wednesday...

Wall Street Zen Upgrades X4 Pharmaceuticals (NASDAQ:XFOR) to "Hold"

Wall Street Zen raised shares of X4 Pharmaceuticals from a "sell" rating to a "hold" rating in a report on Saturday...

MeiraGTx Holdings PLC (MGTX) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

MeiraGTx (MGTX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

X4 Pharmaceuticals (XFOR) Reports Q3 Loss, Misses Revenue Estimates

X4 Pharmaceuticals (XFOR) delivered earnings and revenue surprises of +12.66% and -7.20%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

X4 Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and discovery of novel therapeutics for the treatment of rare diseases and those with limited treatment options. The firm is focused on mavorixafor which is being marketed in the U.S. under the trade name xolremdi. The company was founded by Henri A. Termeer, Keith T. Flaherty, Renato T. Skerlj, Richard Peters and Paula Ragan in 2010 and is headquartered in Boston, MA.

X4 Pharmaceuticals Inc

Short-Term Volatility, Then Markets Move On

Sustained Risk-Off Until Fed Path Is Clear

Little Impact — Fundamentals Still Rule

Other – Comment Below

Markets pulled back after reports that the DOJ opened a criminal investigation into Federal Reserve Chair Jerome Powell, raising concerns about central bank independence. With rate cuts, inflation, and political pressure all in focus, how do you think this standoff will impact markets in 2026?

How Will the Powell Investigation Impact Markets in 2026?

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.26	--	--	N/A
Q3 '25	-$0.50	-$0.69	-36.63%	MISSED
Q2 '25	-$3.37	--	--	N/A
Q1 '25	-$3.55	$0.04	101.13%	BEAT
Q4 '24	-$0.17	-$6.00	-3328.57%	MISSED

XFOR
X4 Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest XFOR News

XFORX4 Pharmaceuticals Inc